| Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura LA Völker, J Kaufeld, W Miesbach, S Brähler, M Reinhardt, L Kühne, ... Blood advances 4 (13), 3085-3092, 2020 | 112 | 2020 |
| Mutations in NEK8 link multiple organ dysplasia with altered Hippo signalling and increased c-MYC expression V Frank, S Habbig, MP Bartram, T Eisenberger, HE Veenstra-Knol, ... Human molecular genetics 22 (11), 2177-2185, 2013 | 108 | 2013 |
| A flexible, multilayered protein scaffold maintains the slit in between glomerular podocytes F Grahammer, C Wigge, C Schell, O Kretz, J Patrakka, S Schneider, ... JCI insight 1 (9), 2016 | 96 | 2016 |
| ADAMTS13 and VWF activities guide individualized caplacizumab treatment in patients with aTTP LA Völker, J Kaufeld, W Miesbach, S Brähler, M Reinhardt, L Kühne, ... Blood advances 4 (13), 3093-3101, 2020 | 61 | 2020 |
| Treatment of acquired thrombotic thrombocytopenic purpura without plasma exchange in selected patients under caplacizumab LA Völker, PT Brinkkoetter, PN Knöbl, M Krstic, J Kaufeld, J Menne, ... Journal of Thrombosis and Haemostasis 18 (11), 3061-3066, 2020 | 50 | 2020 |
| N-degradomic analysis reveals a proteolytic network processing the podocyte cytoskeleton MM Rinschen, AK Hoppe, F Grahammer, M Kann, LA Völker, EM Schurek, ... Journal of the American Society of Nephrology 28 (10), 2867-2878, 2017 | 49 | 2017 |
| Light microscopic visualization of podocyte ultrastructure demonstrates oscillating glomerular contractions M Höhne, C Ising, H Hagmann, LA Völker, S Brähler, B Schermer, ... The American journal of pathology 182 (2), 332-338, 2013 | 49 | 2013 |
| Conditional loss of kidney microRNAs results in congenital anomalies of the kidney and urinary tract (CAKUT) MP Bartram, M Höhne, C Dafinger, LA Völker, M Albersmeyer, J Heiss, ... Journal of Molecular Medicine 91, 739-748, 2013 | 47 | 2013 |
| Comparative analysis of Neph gene expression in mouse and chicken development LA Völker, M Petry, M Abdelsabour-Khalaf, H Schweizer, F Yusuf, T Busch, ... Histochemistry and cell biology 137, 355-366, 2012 | 37 | 2012 |
| Survival and distribution of injected haematopoietic stem cells in acute kidney injury V Burst, F Pütsch, T Kubacki, LA Völker, MP Bartram, RU Müller, M Gillis, ... Nephrology Dialysis Transplantation 28 (5), 1131-1139, 2013 | 32 | 2013 |
| A functional variant in NEPH3 gene confers high risk of renal failure in primary hematuric glomerulopathies. Evidence for predisposition to microalbuminuria in the … K Voskarides, C Stefanou, M Pieri, P Demosthenous, K Felekkis, M Arsali, ... PLoS One 12 (3), e0174274, 2017 | 27 | 2017 |
| Characterization of a short isoform of the kidney protein podocin in human kidney LA Völker, EM Schurek, MM Rinschen, J Tax, BA Schutte, T Lamkemeyer, ... BMC nephrology 14, 1-8, 2013 | 26 | 2013 |
| A disease-causing mutation illuminates the protein membrane topology of the kidney-expressed prohibitin homology (PHB) domain protein podocin EM Schurek, LA Völker, J Tax, T Lamkemeyer, MM Rinschen, D Ungrue, ... Journal of Biological Chemistry 289 (16), 11262-11271, 2014 | 23 | 2014 |
| First use of the anti‐VWF nanobody caplacizumab to treat iTTP in pregnancy. L Kühne, LA Völker, H Hagmann, H Hägele, T Osterholt, DA Eichenauer, ... British Journal of Haematology 196 (3), 2022 | 22 | 2022 |
| Neph2/Kirrel3 regulates sensory input, motor coordination, and home‐cage activity in rodents LA Völker, BA Maar, BA Pulido Guevara, A Bilkei‐Gorzo, A Zimmer, ... Genes, Brain and Behavior 17 (8), e12516, 2018 | 19 | 2018 |
| Alternate‐day dosing of caplacizumab for immune‐mediated thrombotic thrombocytopenic purpura L Kühne, J Kaufeld, LA Völker, R Wendt, U Schönermarck, H Hägele, ... Journal of Thrombosis and Haemostasis 20 (4), 951-960, 2022 | 17 | 2022 |
| Impact of first-line use of caplacizumab on treatment outcomes in immune thrombotic thrombocytopenic purpura LA Völker, J Kaufeld, G Balduin, L Merkel, L Kühne, DA Eichenauer, ... Journal of Thrombosis and Haemostasis 21 (3), 559-572, 2023 | 16 | 2023 |
| Five years of caplacizumab–lessons learned and remaining controversies in immune-mediated thrombotic thrombocytopenic purpura LA Völker, PT Brinkkoetter, SR Cataland, C Masias Journal of Thrombosis and Haemostasis 21 (10), 2718-2725, 2023 | 6 | 2023 |
| Repetitive administration of rituximab can achieve and maintain clinical remission in patients with MCD or FSGS T Osterholt, P Todorova, L Kühne, R Ehren, LT Weber, F Grundmann, ... Scientific Reports 13 (1), 6980, 2023 | 6 | 2023 |
| A case report of recurrent membranoproliferative glomerulonephritis after kidney transplantation due to ventriculoatrial shunt infection LA Völker, K Burkert, N Scholten, F Grundmann, C Kurschat, T Benzing, ... BMC nephrology 20, 1-6, 2019 | 6 | 2019 |
